Az angiogenesis és mediátorai. Patogenetikai és klinikai jelentöségük "angiogén betegségekben".

Translated title of the contribution: Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"

Research output: Contribution to journalArticle

Abstract

Angiogenesis, the production of new blood vessels, plays an important role in a number of physiological and pathological processes, such as development, tissue repair, atherosclerosis, ischemic heart diseases, inflammation and tumor progression. A number of mediators including cytokines, heparin-dependent and -independent growth factors, proteolytic enzymes, extracellular matrix components, cellular adhesion molecules and others, have been implicated in angiogenesis. Certain angiostatic cytokines, growth factor antagonists, steroids, protease inhibitors, antibiotics, antirheumatic drugs, tissue-derived inhibitors and others inhibit neovascularization. Angiogenesis research has important clinical relevance, as targeting angiogenic and angiostatic processes by using angiogenesis inhibitors, receptor antagonists, antibodies, enzyme inhibitors, tumor suppressor genes and other forms of gene therapy, may be a potential therapeutic tool in "angiogenic diseases".

Original languageHungarian
Pages (from-to)227-234
Number of pages8
JournalOrvosi Hetilap
Volume139
Issue number5
Publication statusPublished - Feb 1 1998

Fingerprint

Angiotensins
Intercellular Signaling Peptides and Proteins
Physiological Phenomena
Cytokines
Heart Neoplasms
Antirheumatic Agents
Angiogenesis Inhibitors
Enzyme Inhibitors
Pathologic Processes
Protease Inhibitors
Tumor Suppressor Genes
Genetic Therapy
Myocardial Ischemia
Extracellular Matrix
Blood Vessels
Heparin
Atherosclerosis
Peptide Hydrolases
Steroids
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az angiogenesis és mediátorai. Patogenetikai és klinikai jelentöségük "angiogén betegségekben". / Szekanecz, Z.; Bordán, E.; Szabó, Z.; Szegedi, G.

In: Orvosi Hetilap, Vol. 139, No. 5, 01.02.1998, p. 227-234.

Research output: Contribution to journalArticle

@article{799c6c94553446349542551ab81cde5e,
title = "Az angiogenesis {\'e}s medi{\'a}torai. Patogenetikai {\'e}s klinikai jelent{\"o}s{\'e}g{\"u}k {"}angiog{\'e}n betegs{\'e}gekben{"}.",
abstract = "Angiogenesis, the production of new blood vessels, plays an important role in a number of physiological and pathological processes, such as development, tissue repair, atherosclerosis, ischemic heart diseases, inflammation and tumor progression. A number of mediators including cytokines, heparin-dependent and -independent growth factors, proteolytic enzymes, extracellular matrix components, cellular adhesion molecules and others, have been implicated in angiogenesis. Certain angiostatic cytokines, growth factor antagonists, steroids, protease inhibitors, antibiotics, antirheumatic drugs, tissue-derived inhibitors and others inhibit neovascularization. Angiogenesis research has important clinical relevance, as targeting angiogenic and angiostatic processes by using angiogenesis inhibitors, receptor antagonists, antibodies, enzyme inhibitors, tumor suppressor genes and other forms of gene therapy, may be a potential therapeutic tool in {"}angiogenic diseases{"}.",
author = "Z. Szekanecz and E. Bord{\'a}n and Z. Szab{\'o} and G. Szegedi",
year = "1998",
month = "2",
day = "1",
language = "Hungarian",
volume = "139",
pages = "227--234",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "5",

}

TY - JOUR

T1 - Az angiogenesis és mediátorai. Patogenetikai és klinikai jelentöségük "angiogén betegségekben".

AU - Szekanecz, Z.

AU - Bordán, E.

AU - Szabó, Z.

AU - Szegedi, G.

PY - 1998/2/1

Y1 - 1998/2/1

N2 - Angiogenesis, the production of new blood vessels, plays an important role in a number of physiological and pathological processes, such as development, tissue repair, atherosclerosis, ischemic heart diseases, inflammation and tumor progression. A number of mediators including cytokines, heparin-dependent and -independent growth factors, proteolytic enzymes, extracellular matrix components, cellular adhesion molecules and others, have been implicated in angiogenesis. Certain angiostatic cytokines, growth factor antagonists, steroids, protease inhibitors, antibiotics, antirheumatic drugs, tissue-derived inhibitors and others inhibit neovascularization. Angiogenesis research has important clinical relevance, as targeting angiogenic and angiostatic processes by using angiogenesis inhibitors, receptor antagonists, antibodies, enzyme inhibitors, tumor suppressor genes and other forms of gene therapy, may be a potential therapeutic tool in "angiogenic diseases".

AB - Angiogenesis, the production of new blood vessels, plays an important role in a number of physiological and pathological processes, such as development, tissue repair, atherosclerosis, ischemic heart diseases, inflammation and tumor progression. A number of mediators including cytokines, heparin-dependent and -independent growth factors, proteolytic enzymes, extracellular matrix components, cellular adhesion molecules and others, have been implicated in angiogenesis. Certain angiostatic cytokines, growth factor antagonists, steroids, protease inhibitors, antibiotics, antirheumatic drugs, tissue-derived inhibitors and others inhibit neovascularization. Angiogenesis research has important clinical relevance, as targeting angiogenic and angiostatic processes by using angiogenesis inhibitors, receptor antagonists, antibodies, enzyme inhibitors, tumor suppressor genes and other forms of gene therapy, may be a potential therapeutic tool in "angiogenic diseases".

UR - http://www.scopus.com/inward/record.url?scp=17144467448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144467448&partnerID=8YFLogxK

M3 - Article

C2 - 9489376

AN - SCOPUS:17144467448

VL - 139

SP - 227

EP - 234

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 5

ER -